A last-minute Brexit scramble.
Tag: BioNTech SE
E.U. Agency Approves Pfizer Covid Vaccine
In a landmark collective undertaking, the bloc is poised to start distributing shots to all 27 member nations and their 410 million citizens.
Your Wednesday Briefing
Poorer nations struggle to access a coronavirus vaccine.
A Vaccine Is on Its Way to Canada. Who Will Get It First?
Determining how to parcel out the long-awaited vaccine is not a simple task for the provinces.
F.D.A. Panel Gives Green Light to Pfizer’s Covid Vaccine
The blessing of these experts means that the agency will likely OK the vaccine’s use, paving the way for health care workers to begin getting shots next week.
U.K. Covid Vaccine: Side Effects, Safety, and Who Gets It First
The mass inoculation campaign that began in Britain on Tuesday has little precedent in modern medicine.
U.K. Tackles Giant Vaccine Rollout After Botched Covid Response
Britain left hospitals short of masks and gowns, and stumbled on testing and tracing, so can it vaccinate tens of millions of people in a matter of months? Experts think it can.
For Boris Johnson, Vaccine Rollout Offers Last Chance to Show Competence
With the vaccine rollout and a potential Brexit deal looming, his government has a chance to wash away its reputation for chaos and mismanagement.
The UK Just Approved the Pfizer Covid Vaccine. What Happens Next?
When early results from the final trials began to roll in, scientists were well prepared. Now, they face the logistical challenge of putting the vaccine to work.
U.K. Approves Pfizer Coronavirus Vaccine, a First in the West
The emergency approval, ahead of the United States and the European Union, clears the way for Britain to begin mass inoculations. “Help is on its way,” one official said.